KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 Genetic Test
Test Name: KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 Genetic Test
Components: KCNE1 gene sequencing using NGS technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 NGS Genetic DNA Test gene KCNE1
Test Details: The KCNE1 gene is a gene that provides instructions for making a protein called potassium voltage-gated channel subfamily E regulatory subunit 1. This protein plays a role in regulating the flow of potassium ions across cell membranes, which is important for the normal function of the heart. Jervell and Lange-Nielsen Syndrome Type 2 (JLNS2) is a rare genetic disorder characterized by a combination of deafness and a heart condition called long QT syndrome (LQTS). LQTS is a disorder of the heart’s electrical system that can lead to irregular heartbeats and fainting spells. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the KCNE1 gene, to identify genetic mutations or variations that may be associated with a particular condition or disease. Therefore, a KCNE1 gene Jervell and Lange-Nielsen Syndrome Type 2 NGS genetic test would involve sequencing the KCNE1 gene using next-generation sequencing technology to identify any genetic mutations or variations that may be associated with Jervell and Lange-Nielsen Syndrome Type 2. This test can help in confirming a diagnosis, predicting disease progression, and guiding treatment decisions for individuals suspected to have this syndrome.
Test Name | KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 NGS Genetic DNA Test gene KCNE1 |
Test Details | The KCNE1 gene is a gene that provides instructions for making a protein called potassium voltage-gated channel subfamily E regulatory subunit 1. This protein plays a role in regulating the flow of potassium ions across cell membranes, which is important for the normal function of the heart. Jervell and Lange-Nielsen syndrome type 2 (JLNS2) is a rare genetic disorder characterized by a combination of deafness and a heart condition called long QT syndrome (LQTS). LQTS is a disorder of the heart’s electrical system that can lead to irregular heartbeats and fainting spells. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the KCNE1 gene, to identify genetic mutations or variations that may be associated with a particular condition or disease. Therefore, a KCNE1 gene Jervell and Lange-Nielsen syndrome type 2 NGS genetic test would involve sequencing the KCNE1 gene using next-generation sequencing technology to identify any genetic mutations or variations that may be associated with Jervell and Lange-Nielsen syndrome type 2. This test can help in confirming a diagnosis, predicting disease progression, and guiding treatment decisions for individuals suspected to have this syndrome. |